Medtronic plc
MDTMedtronic plc is a global leader in medical technology, specializing in medical devices, therapies, and solutions for various chronic diseases. Founded in 1949 and headquartered in Ireland, the company develops products for areas such as cardiac and vascular care, diabetes management, neurological disorders, and surgical equipment, aiming to improve patient outcomes and healthcare efficiency worldwide.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| July 17, 2026 | $0.72 | 2026-06-26 | 2026-06-26 |
| April 17, 2026 | $0.71 | 2026-03-27 | 2026-03-27 |
| January 16, 2026 | $0.71 | 2025-12-26 | 2025-12-26 |
| October 17, 2025 | $0.71 | 2025-09-26 | 2025-09-26 |
| July 11, 2025 | $0.71 | 2025-06-27 | 2025-06-27 |
Dividends Summary
- Consistent Payer: Medtronic plc has rewarded shareholders with 90 dividend payments over the past 22 years.
- Total Returned Value: Investors who held MDT shares during this period received a total of $34.47 per share in dividend income.
- Latest Payout: The most recent dividend of $0.72/share was paid 1 days ago, on July 17, 2026.
- Yield & Schedule: MDT currently pays dividends quarterly with an annual yield of 3.43%.
- Dividend Growth: Since 2004, the dividend payout has grown by 893.1%, from $0.07 to $0.72.
- Dividend Reliability: MDT has maintained or increased its dividend for 90 consecutive payments.
Company News
The global blood glucose monitoring system market is valued at USD 16.8 billion in 2025 and is projected to reach USD 39.4 billion by 2035, growing at a CAGR of 8.9%. Growth is driven by AI-enabled monitoring systems, increasing diabetes prevalence, and rising adoption of home healthcare solutions. Key players include Medtronic, Abbott, Dexcom, a...
The global disposable endoscopes market is expected to expand at a CAGR of 15.04% through 2035, driven by rising infection prevention initiatives, adoption of single-use endoscopes, and minimally invasive procedures. North America leads with 38.45% market share, while Asia Pacific records the fastest growth. Hospitals dominate the end-user segmen...
The AI in orthopedic surgery market is experiencing remarkable growth with a projected CAGR of 27.2% through 2030. Key drivers include rising musculoskeletal disorders, AI-assisted surgical planning, robotic surgical systems integration, and enhanced implant placement precision. North America leads the market, while Asia-Pacific and Europe show g...
A comprehensive patent landscape analysis of surgical navigation systems reveals 2,524 patents filed globally from 2010-2025, with the United States leading at 1,204 patents. The global market was valued at USD 8.38 billion in 2024 and is projected to reach USD 18.47 billion by 2030 at a 14% CAGR. Key drivers include AI-guided support, augmented ...
The global Smart Hospitals Market is projected to grow from USD 90.82 billion in 2026 to USD 206.71 billion by 2032, with a CAGR of 14.56%. Growth is driven by AI integration, connected medical devices, and digital health initiatives across APAC, Europe, and North America. Key focus areas include precision medicine, operational efficiency, and cy...
Related Companies
